Provided by Tiger Trade Technology Pte. Ltd.

Hepion Pharmaceuticals, Inc.

0.0800
+0.010014.29%
Volume:20.26K
Turnover:1.51K
Market Cap:929.63K
PE:-0.02
High:0.0800
Open:0.0695
Low:0.0650
Close:0.0700
52wk High:36.73
52wk Low:0.0330
Shares:11.62M
Float Shares:11.62M
Volume Ratio:2.79
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7288
EPS(LYR):-107.3480
ROE:-628.46%
ROA:-72.99%
PB:0.57
PE(LYR):0.00

Loading ...

Jan 16, 2025

Correspondence

Form CORRESP - Correspondence
Jan 16, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Correspondence

Form CORRESP - Correspondence
Jan 14, 2025

Correspondence

Form CORRESP - Correspondence
Jan 14, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 13, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Dec 26, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 05, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 12, 2024

Correspondence

Form CORRESP - Correspondence